AIMMUNE THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Dec 2024)
What this means for you
This application is over — abandoned 23 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90019081
- Mark type
- Design + words
- Filed
- 24 Jun 2020
- Published for opposition
- 24 Nov 2020
- Abandoned
- 23 Dec 2024
- Attorney of record
- Catherine C. Miller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating allergies
Owner
- Société des Produits Nestlé S.A., Vevey, CH
- Aimmune Therapeutics, Inc., Brisbane, CA, US
- Aimmune Therapeutics, Inc., Brisbane, CA, US
Prosecution history
- 23 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 15 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2024 — SOU EXTENSION 4 GRANTED
- 14 May 2024 — SOU EXTENSION 4 FILED
- 14 May 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2023 — SOU EXTENSION 3 GRANTED
- 19 Oct 2023 — SOU EXTENSION 3 FILED
- 19 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 02 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2023 — SOU EXTENSION 2 GRANTED
- 28 Apr 2023 — SOU EXTENSION 2 FILED
- 28 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Nov 2022 — ASSIGNED TO EXAMINER